GlassScriptPhysician profile
Laurel Roberts
NPI 1396242533
$7,127.20
in general payments reported to CMS, 2019-2025
11 companies · $977 in 2025
The $977 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,086 · 2020: $237 · 2021: $157 · 2022: $446 · 2023: $637 · 2024: $1,587 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141 · Travel and Lodging: $1,110 · Consulting Fee: $600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.67 |
| Travel and Lodging | $1,109.93 |
| Consulting Fee | $600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,697.50 | 2019-2025 | Air Optix, Total30, Tryptyr |
| Valley Contax, INC. | $1,518.12 | 2019 | |
| Coopervision INC. | $698.18 | 2021-2025 | Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $336.61 | 2022-2025 | Acuvue |
| Harrow Eye, LLC | $291.17 | 2024-2025 | Natacyn, Tobradex St, Flarex |
| Glaukos Corporation | $175.40 | 2025 | Photrexa Viscous and Photrexa |
| Biotissue Holdings INC. | $157.78 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.34 | 2021 | |
| Dompe US, INC. | $87.62 | 2021-2024 | Oxervate |
| Carl Zeiss Meditec, INC. | $33.00 | 2022 | |
| Bausch & Lomb Americas INC. | $19.48 | 2023 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.